Evidence mapPaperPMID 37572792Full record

ArticlePeptides2023

Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.

Nathalie Esser, Stephen M Mongovin, Thomas O Mundinger, Breanne M Barrow, Sakeneh Zraika

Open access · greenAbstract read
In one paragraph

Article in Peptides, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Nathalie EsserVeterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States; Laboratory of Immunometabolism and Nutrition, GIGA-I3, CHU Liège, University of Liège, Liège, Belgium.
Stephen M MongovinVeterans Affairs Puget Sound Health Care System, Seattle, WA, United States.
Thomas O MundingerDivision of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States.
Breanne M BarrowVeterans Affairs Puget Sound Health Care System, Seattle, WA, United States.
Sakeneh ZraikaVeterans Affairs Puget Sound Health Care System, Seattle, WA, United States; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA, United States. Electronic address: zraikas@uw.edu.
University of Washington · USVA Puget Sound Health Care System · USUniversity of Liège · BE

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · 1986 to 2025
$12.6M
NIDDK NIH HHS P30 DK017047NIDDK NIH HHS R01 DK098506
6 · The paper itself

Abstract

Neprilysin is a peptidase that cleaves glucoregulatory peptides, including glucagon-like peptide-1 (GLP-1) and cholecystokinin (CCK). Some studies suggest that its inhibition in diabetes and/or obesity improves glycemia, and that this is associated with enhanced insulin secretion, glucose tolerance and insulin sensitivity. Whether reduced neprilysin activity also improves hepatic glucose metabolism has not been explored. We sought to determine whether genetic deletion of neprilysin suppresses hepatic glucose production (HGP) in high fat-fed mice. Nep

Indexed as

Diabetes Mellitus, Type 2GluconeogenesisAnimalsBlood GlucoseGlucagon-Like Peptide 1GlucoseInsulinLiverLiver GlycogenMiceNeprilysinObesityBlood GlucoseGlucagon-Like Peptide 1GlucoseInsulinLiver GlycogenNeprilysinCholecystokininGlucagon-like peptide-1GluconeogenesisGlycogenolysisLiverNeprilysin

Identifiers

PMID37572792
PMCPMC10529503
OpenAlexW4385725618

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.